Back to feed
AYTUAYTU BIOPHARMA, INC
CIK 0001385818 · no recent filings · 0 insider transactions
Buy volume
$0
0 buy transactions
Sell volume
$0
0 sell transactions
Net flow
+$0
Net buying
Total flow
$0
0 priced transactions
Disclosure radarcross-source convergence
Institution-led2/5 sources
18/100
Recent disclosures · timeline
- 8-K1.023d ago
Termination of a material agreement
Price · AYTU
Live chart by TradingViewLive chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
Material events · 8-K
AYTU corporate events · live SEC data- 1.02Material3d ago
Termination of a material agreement
Form 8-K — items reported: 1.02 Termination of a material agreement.
Item 1.02 · Termination of a material agreementView 8-K on EDGAR ↗
Institutional holders · 13F
Q1 2026 vs Q4 2025 · live SEC data5 funds hold$1.48M reported valueNet accumulating(3 adding · 0 reducing)
| Fund | Shares | Value | % of portfolio | QoQ |
|---|---|---|---|---|
| Vanguard Group Inc | 278,583 | $724.3K | 0.0% | Hold |
| Two Sigma Investments LP | 121,973 | $333.0K | 0.0% | Add+14% |
| Renaissance Technologies LLC Jim Simons (founder) | 93,723 | $255.9K | 0.0% |
Recent insider transactions
No insider transactions recorded for AYTU.